Recent Finacing
Recent Raise
PetDx develops OncoK9, a cfDNA next-generation sequencing and proprietary bioinformatics multi-cancer early-detection blood test for dogs, clinically validated across about 30 cancer types and used in veterinary clinics.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors
See the team members at PetDx.
